New type 2 diabetes pill, Tradjenta, approved
A new type 2 diabetes pill known as Tradjenta from Boehringer, a German company, and Indianapolis-based Eli Lilly & Co. has been approved by the Food and Drug Administration.
The FDA approved Bydureon, which the companies called the first once-weekly treatment for Type 2 diabetes.